You have 9 free searches left this month | for more free features.

Lymphocytes

Showing 1 - 25 of 6,538

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Liver Cancer Trial in Wuhan (Autologous Tumor Infiltrating Lymphocytes)

Recruiting
  • Liver Cancer
  • Autologous Tumor Infiltrating Lymphocytes
  • Wuhan, China
    Tongji Hospital
Oct 9, 2023

Glomerulonephritis, IGA Trial in Besançon (Blood collection, Urine sample)

Not yet recruiting
  • Glomerulonephritis, IGA
  • Blood collection
  • Urine sample
  • Besançon, France
    Centre Hospitalier Universitaire de Besançon
Mar 17, 2023

Platelets to Lymphocytes Ratio and Monocytes to Lymphocytes

Recruiting
  • Cirrhotic Patients With Spontaneous Bacterial Peritonitis
  • ascetic fluid study
  • Sohag, Egypt
    Sohag University Hospital
Apr 30, 2023

Granuloma, Aluminum Allergy Trial in Hellerup (Aluminum, Tetanus toxoid)

Completed
  • Granuloma
  • Aluminum Allergy
  • Aluminum
  • Tetanus toxoid
  • Hellerup, Denmark
    National Allergy Research Centre, Gentofte Hospital
Nov 8, 2023

CMV Viremia, CMV Trial in São Paulo (Lymphocyte infusion (ImmuneCellVir-I))

Recruiting
  • CMV Viremia
  • CMV
  • Lymphocyte infusion (ImmuneCellVir-I)
  • São Paulo, SP, Brazil
    Hospital Israelita Albert Einstein
Aug 21, 2023

Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)

Not yet recruiting
  • Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Jun 5, 2023

Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan,

Not yet recruiting
  • Metastatic Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Oct 14, 2022

Lymphocytes, Tumor-Infiltrating Trial in Saint Petersburg (Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide,

Not yet recruiting
  • Lymphocytes
  • Tumor-Infiltrating
  • Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide, Interleukin-2
  • Saint Petersburg, Florida
  • +1 more
Sep 15, 2023

JAK-i on RA B-lymphocytes Tolerance and Disease Resolution

Recruiting
  • Rheumatoid Arthritis
  • B lymphocyte profiling
  • Rome, Italy
    Division of Clinical Immunology, Fondazione Policlinico Universi
Feb 22, 2023

Platelets to Lymphocytes Ratio Sepsis Trial in Tanta (Platelets to lymphocytes ratio and procalcitonin)

Recruiting
  • Platelets to Lymphocytes Ratio Sepsis
  • Platelets to lymphocytes ratio and procalcitonin
  • Tanta, Egypt
    Tanta university of medicine
May 28, 2022

Circulating Cluster of Differentiation 4 Positive 28 Null T

Not yet recruiting
  • Autoimmune Hemolytic Anemia
    • (no location specified)
    Jan 31, 2023

    Digestive System Malignant Solid Tumors Trial (ScTIL injection, ScTIL injection and B lymphocytes adjuvant)

    Not yet recruiting
    • Digestive System Malignant Solid Tumors
    • ScTIL injection
    • ScTIL injection and B lymphocytes adjuvant
    • (no location specified)
    Feb 7, 2023

    Adenovirus Infection Trial in Columbus (Adenovirus Specific T lymphocytes)

    Recruiting
    • Adenovirus Infection
    • Adenovirus Specific T lymphocytes
    • Columbus, Ohio
      Nationwide Children's Hospital
    Sep 1, 2022

    Metastatic Melanoma Trial run by the National Cancer Institute (NCI) (Aldesleukin, Fludarabine, Cyclophosphamide)

    Completed
    • Metastatic Melanoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 21, 2022

    Neutrophils to Lymphocytes Ratio in Predicting Response to BCG

    Completed
    • Urinary Bladder Cancer
    • +4 more
    • Neutrophil to lymphocyte ratio
    • Cairo, Egypt
      Ain Shams university
    Jul 15, 2023

    COVID-19 Trial in Sukoharjo (Calcitriol, Placebo)

    Completed
    • COVID-19
    • Sukoharjo, Central Java, Indonesia
      Universitas Sebelas Maret Hospital
    Mar 9, 2023

    Burnout Syndrome, Neutrophil-Lymphocyte Ratio, Interleukin-6 Trial (music therapy)

    Not yet recruiting
    • Burnout Syndrome
    • +3 more
    • music therapy
    • (no location specified)
    Feb 20, 2023

    Lung Cancer Trial in Houston (NKTR-255, Durvalumab)

    Not yet recruiting
    • Lung Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 30, 2022

    Breast Tumors Trial in Guangzhou (procedure, drug, biological)

    Recruiting
    • Breast Neoplasms
    • Surgery for harvesting tumor-draining lymph nodes
    • +6 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Nov 2, 2023

    Breast Tumors Trial in Guangzhou (procedure, drug, biological)

    Recruiting
    • Breast Neoplasms
    • Surgery for harvesting tumor-draining lymph nodes
    • +8 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Jul 31, 2023

    Breast Tumors Trial in Guangzhou (procedure, drug, biological)

    Recruiting
    • Breast Neoplasms
    • Sentinel Lymph Node Biopsy (SLNB)
    • +7 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Nov 2, 2023

    Leukapheresis Procedures to Obtain Plasma and Lymphocytes for

    Recruiting
    • HIV
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 7, 2023

      Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

      Recruiting
      • Urothelial Carcinoma
      • Non-Invasive Bladder Urothelial Carcinoma
      • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
      • Tampa, Florida
        Moffitt Cancer Center
      Mar 2, 2023

      Uveal Tumors, Melanoma, Uveal Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))

      Recruiting
      • Uveal Neoplasms
      • Melanoma, Uveal
      • Tumor Infiltrating Lymphocytes (TIL)
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Jul 21, 2022

      Metastatic Melanoma Trial in New Haven (Tumor Infiltrating Lymphocytes, Nivolumab and Ipilimumab)

      Terminated
      • Metastatic Melanoma
      • Tumor Infiltrating Lymphocytes
      • Nivolumab and Ipilimumab
      • New Haven, Connecticut
        Yale New Haven Hospital
      Jul 20, 2022